Q3 Provider Webinar – September 2023 September 7, 2023 Get the latest updates from our Pharmacy Department on the new prior authorization process for Specialty Fusion. Learn what alternative biosimilars will be required instead of Humira. You can go directly to the part of the presentation you’d like to watch by clicking on the links below or view the entire webinar. Topics include: Specialty Fusion prior authorization process. Humira biosimilars. IHN-CCO sterilization consent reminder. Genetic prior authorization changes in 2024. New gender specific modifiers. Outreach & education reminders. Watch the Webinar in Full
